Key result
Intravenous atenolol prolongs sinus cycle length, AV nodal conduction, and atrial refractoriness in suspected CAD.
Why the study?
The electrophysiological effects of atenolol, a new cardioselective beta-blocking agent, needed characterization in patients with suspected coronary artery disease.
Does intravenous atenolol alter cardiac electrophysiological parameters in patients with suspected coronary artery disease?
Does intravenous atenolol alter cardiac electrophysiological parameters in patients with suspected coronary artery disease?
Intravenous atenolol significantly prolongs AV nodal conduction and atrial refractoriness without affecting the His Purkinje system or ventricular refractory periods, suggesting potential utility for atrial arrhythmias.
Answers are grounded in this paper and cite their sources.
May warrant conduction monitoring with IV atenolol in CAD; leaves open comparative trials versus modern agents.
Atenolol, a cardioselective beta-blocking agent, at dose levels of 0.03, 0.06, and 0.12 mg/kg intravenously, produced prolongation of atrioventricular nodal conduction in 22 patients with suspected coronary artery disease. In a dose of 0.12 mg/kg body weight atenolol produced significant prolongation of sinus cycle length, sinus node recovery time, atrioventricular node conduction, and the effective and functional refractory periods of the atrium and the atrioventricular node. No significant effects were observed on the His Purkinje system or the effective refractory periods of the ventricle. In these actions atenolol closely resembles propranolol. However, because in contrast to propranolol it increases atrial refractoriness, it may have advantages in the treatment of atrial arrhythmias.
No takes yet. Share an insight, caveat, or question.
Robinson et al. (1978) studied suspected coronary artery disease (n=22). Atenolol was evaluated on atrioventricular nodal conduction and other electrophysiological parameters. Intravenous atenolol produced significant prolongation of sinus cycle length, atrioventricular node conduction, and atrial refractory periods in patients with suspected coronary artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: